Cytokine-induced sickness behavior: Mechanisms and implications

Annals of the New York Academy of Sciences

Volumn 933, Issue , 2001, Pages 222-234

  Dantzer, Robert ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIDEPRESSANT AGENT; CYTOKINE; IMIPRAMINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

BEHAVIOR; CONFERENCE PAPER; DEPRESSION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; ILLNESS BEHAVIOR; IMMUNE SYSTEM; INFLAMMATION; MOTIVATION; NERVE CELL PLASTICITY; NONHUMAN; SYMPTOMATOLOGY;

EID: 0035038172     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb05827.x     Document Type: Conference Paper

References (65)

1. Biological basis of the behavior of sick animals
2. Sickness behavior as a new target for drug development
3. Interleukin-1 induces conditioned taste aversion in rats: A possible explanation for its pituitary-adrenal stimulating activity
4. Aversive effects of centrally injected interleukin-1 are independent of its pyrogenic activity
5. A test of conditioned taste aversion with mouse interferon-α
6. Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat
7. Mechanisms of the behavioral effects of interleukin-1: Role of prostaglandins and CRF
8. Synergy between tumor necrosis factor α and interleukin-1 in the induction of sickness behavior in mice
9. Mechanisms of sickness-induced decreases in food-motivated behavior
10. Cytokines and ingestive behavior: Methods and overview
11. Induction of tumor necrosis factor-α mRNA in the brain after peripheral endotoxin treatment: Comparison with interleukin-1 family and interleukin-6
12. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice
13. Appearance of interleukin-1 in macrophages and ramified microglia in the brain of endotoxin-treated rats: A pathway for the induction of nonspecific symptoms of sickness
14. Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin-1
15. Neural and biochemical mediators of endotoxin and stress-induced c-fos expression in the rat brain
16. Lipopolysaccharide induces sickness behavior in rats by a vagal mediated mechanism
17. Vagotomy attenuates behavioral effects of interleukin-1 injected peripherally, but not centrally
18. Subdiaphragmatic vagotomy blocks induction of IL-1β mRNA in mice brain in response to peripheral LPS
19. Vagotomy blocks the induction of interleukin-1 beta (IL-1 beta) mRNA in the brain of rats in response to systemic IL-1 beta
20. Interleukin-1 beta in immune cells of the abdominal vagus nerve: A link between the nervous and immune systems?
21. Glutamate release in the nucleus tractus solitarius induced by peripheral lipopolysaccharide and interleukin-1 beta
22. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons
23. The organization of noradrenergic pathways from the brain stem to the paraventricular and supraoptic nuclei in the rat
24. Immune stimulation induces Fos expression in brain stem amygdala afferents
25. Involvement of cyclooxygenase-2 in LPS-induced fever and regulation of its mRNA by LPS in the rat brain
26. Temporal and spatial relationships between lipopolysaccharide-induced expression of Fos, interleukin-1β, and inducible nitric oxide synthase in rat brain
27. Species-specific defense reactions and avoidance learning
28. Some psychophysiological studies of motivation and of the behavioral effects of illness
29. Compared effects of cold ambient temperature and cytokines on macronutrient intake in rats
30. Differential effects of lipopolysaccharide on pup retrieving and nest building in lactating mice
31. Differential effects of lipopolysaccharide on food hoarding behavior and food consumption in rats
32. Sensitization to the effects of tumor necrosis factor-alpha: Neuroendocrine, central monoamine, and behavioral variations
33. Cross-sensitization between immune and nonimmune stressors: A role in the etiology of depression?
34. The neuroendocrine effects of interleukin-2 treatment
35. Modulation of body temperature through taste aversion conditioning
36. Conditioning the elevation of body temperature, a host defensive reflex response
37. Behavioral conditioning of lipopolysaccharide-induced anorexia
38. Pavlovian conditioning of LPS-induced responses: Effects on corticosterone, splenic NE, and IL-2 production
39. Acute-phase immune response: Lipopolysaccharide-induced fever and sleep alterations are not simultaneously conditionable in the rat during the inactive (light) phase
40. Modification of body temperature and sleep state using behavioral conditioning
41. Effects of interferon alpha in man: A preliminary report
42. Interleukin-1β, but not interleukin-6, impairs spatial navigation learning
43. Spatial learning impairment in mice infected with Legionella pneumophila or administered exogenous interleukin-1β
44. Pyrogens specifically disrupt the acquisition of a task involving cognitive processing in the rat
45. Chronic fatigue, viruses, and depression
46. Acute phase response and cytokine secretion in chronic fatigue syndrome
47. TNF-alpha and chronic fatigue syndrome
48. Immunological responses in chronic fatigue syndrome following a graded exercise test to exhaustion
49. Changes in immune parameters seen in Gulf War veterans, but not in civilians with chronic fatigue syndrome
50. Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome
51. Cytokine production by adherent and nonadherent mononuclear cells in chronic fatigue syndrome
52. Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome
53. Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome
54. The monocyte-T-lymphocyte hypothesis of major depression
55. Cytokines and depression: Fortuitous or causative association?
56. Early depressive symptoms in cancer patients receiving interleukin-2 and/or interferon alpha-2b therapy
57. Prediction of the depressive effects of interferon alpha therapy by the patient's initial affective state
58. Effects of cytokines on glucocorticoid receptor expression and function: Glucocorticoid resistance and relevance to depression
59. Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock
60. Anhedonic and anxiogenic effects of cytokine exposure
61. Endotoxin produces a depressive-like episode in rats
62. Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral, but not central lipopolysaccharide and interleukin-1β in the rat
63. Serum neopterin and somatization in women with chemical intolerance, depressives, and normals